{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:04:39Z","timestamp":1792757079068,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00108-025-01891-8","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T17:49:37Z","timestamp":1743702577000},"page":"686-694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Zielorgan Gef\u00e4\u00dfe \u2013 vom Morbus Ormond zu Immunglobulin-G4-assoziierten Erkrankungen","Blood vessels as a\u00a0target organ: from Ormond\u2019s disease to immunoglobulin G4-related diseases"],"prefix":"10.1007","volume":"66","author":[{"given":"Marco","family":"Krasselt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimba","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"1891_CR1","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0091-6749(97)70052-6","volume":"99","author":"CA Akdis","year":"1997","unstructured":"Akdis\u00a0CA, Blesken\u00a0T, Akdis\u00a0M et\u00a0al (1997) Induction and differential regulation of bee venom phospholipase A2-specific human IgE and IgG\u00a04 antibodies in vitro requires allergen-specific and nonspecific activation of T and\u00a0B\u00a0cells. J\u00a0Allergy Clin Immunol 99:345\u2013353","journal-title":"J Allergy Clin Immunol"},{"key":"1891_CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/a-1735-3864","volume":"60","author":"G Beyer","year":"2022","unstructured":"Beyer\u00a0G, Hoffmeister\u00a0A, Michl\u00a0P et\u00a0al (2022) S3-Leitlinie Pankreatitis \u2013 Leitlinie der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z\u00a0Gastroenterol 60:419\u2013521","journal-title":"Z Gastroenterol"},{"key":"1891_CR3","first-page":"1","volume-title":"Die Urologie","author":"AS Brandt","year":"2015","unstructured":"Brandt\u00a0AS, Goedde\u00a0D, Kamper\u00a0L et\u00a0al (2015) Retroperitoneale Fibrose (Morbus Ormond). In: Michel\u00a0MS, Th\u00fcroff\u00a0JW, Janetschek\u00a0G, Wirth\u00a0M (Hrsg) Die Urologie. Springer Berlin Heidelberg, Berlin, Heidelberg, S\u00a01\u201323"},{"key":"1891_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers\u00a0MN, Khosroshahi\u00a0A, Augustin\u00a0T et\u00a0al (2015) The diagnostic utility of serum IgG\u00a04 concentrations in IgG\u00a04-related disease. Ann Rheum Dis 74:14\u201318","journal-title":"Ann Rheum Dis"},{"key":"1891_CR5","doi-asserted-by":"publisher","first-page":"e003498","DOI":"10.1136\/rmdopen-2023-003498","volume":"9","author":"C-T Chang","year":"2023","unstructured":"Chang\u00a0C\u2011T, Chan\u00a0T\u2011M, Yu\u00a0H\u2011H, Yu\u00a0K\u2011H (2023) Diagnostic utility of serum IgG\u00a04 level in IgG\u00a04-related diseases: a\u00a0comprehensive systematic review and meta-analysis. Rmd Open 9:e3498","journal-title":"Rmd Open"},{"key":"1891_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13550-023-00972-9","volume":"13","author":"M Chen","year":"2023","unstructured":"Chen\u00a0M, Tang\u00a0CYL, Fong\u00a0WWS, Lam\u00a0WW (2023) Semi-quantitative indices of 2\u2011((18)F)FDG PET\/CT in assessing cardiovascular and non-cardiovascular manifestations of IgG\u00a04-related disease and treatment response. EJNMMI Res 13:22","journal-title":"EJNMMI Res"},{"key":"1891_CR7","doi-asserted-by":"publisher","first-page":"e0282852","DOI":"10.1371\/journal.pone.0282852","volume":"18","author":"SJ Choi","year":"2023","unstructured":"Choi\u00a0SJ, Ahn\u00a0SM, Oh\u00a0JS et\u00a0al (2023) Serum IgG\u00a04 level during initial treatment as a\u00a0predictor of relapse in IgG\u00a04-related disease. PLoS ONE 18:e282852","journal-title":"PLoS ONE"},{"key":"1891_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1080\/19420862.2017.1323159","volume":"9","author":"G Dekkers","year":"2017","unstructured":"Dekkers\u00a0G, Bentlage\u00a0AEH, Stegmann\u00a0TC et\u00a0al (2017) Affinity of human IgG subclasses to mouse Fc gamma receptors. mAbs 9:767\u2013773","journal-title":"mAbs"},{"key":"1891_CR9","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande\u00a0V, Zen\u00a0Y, Chan\u00a0JK et\u00a0al (2012) Consensus statement on the pathology of IgG\u00a04-related disease. Mod Pathol 25:1181\u20131192","journal-title":"Mod Pathol"},{"key":"1891_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.28568","volume":"64","author":"ME Doorenspleet","year":"2016","unstructured":"Doorenspleet\u00a0ME, Hubers\u00a0LM, Culver\u00a0EL et\u00a0al (2016) Immunoglobulin G4(+) B\u2011cell receptor clones distinguish immunoglobulin\u00a0G 4\u2011related disease from primary sclerosing cholangitis and biliary\/pancreatic malignancies. Hepatology 64:501\u2013507","journal-title":"Hepatology"},{"key":"1891_CR11","doi-asserted-by":"publisher","first-page":"e0125331","DOI":"10.1371\/journal.pone.0125331","volume":"10","author":"H Du","year":"2015","unstructured":"Du\u00a0H, Shi\u00a0L, Chen\u00a0P et\u00a0al (2015) Prohibitin Is Involved in Patients with IgG\u00a04 Related Disease. PLoS ONE 10:e125331","journal-title":"PLoS ONE"},{"key":"1891_CR12","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00535-003-1175-y","volume":"38","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa\u00a0T, Funata\u00a0N, Hayashi\u00a0Y et\u00a0al (2003) A new clinicopathological entity of IgG\u00a04-related autoimmune disease. J\u00a0Gastroenterol 38:982\u2013984","journal-title":"J Gastroenterol"},{"key":"1891_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/MD.0b013e318289610f","volume":"92","author":"A Khosroshahi","year":"2013","unstructured":"Khosroshahi\u00a0A, Carruthers\u00a0MN, Stone\u00a0JH et\u00a0al (2013) Rethinking Ormond\u2019s disease: \u201eidiopathic\u201c retroperitoneal fibrosis in the era of IgG\u00a04-related disease. Medicine 92:82\u201391 (Baltimore)","journal-title":"Medicine"},{"key":"1891_CR14","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi\u00a0A, Wallace\u00a0ZS, Crowe\u00a0JL et\u00a0al (2015) International Consensus Guidance Statement on the Management and Treatment of IgG\u00a04-Related Disease. Arthritis Rheumatol 67:1688\u20131699","journal-title":"Arthritis Rheumatol"},{"key":"1891_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s13075-018-1718-5","volume":"20","author":"M Lanzillotta","year":"2018","unstructured":"Lanzillotta\u00a0M, Della-Torre\u00a0E, Milani\u00a0R et\u00a0al (2018) Increase of circulating memory B\u00a0cells after glucocorticoid-induced remission identifies patients at risk of IgG\u00a04-related disease relapse. Arthritis Res Ther 20:222","journal-title":"Arthritis Res Ther"},{"key":"1891_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/art.41140","volume":"72","author":"H Liu","year":"2020","unstructured":"Liu\u00a0H, Perugino\u00a0CA, Ghebremichael\u00a0M et\u00a0al (2020) Disease Severity Linked to Increase in Autoantibody Diversity in IgG\u00a04-Related Disease. Arthritis Rheumatol 72:687\u2013693","journal-title":"Arthritis Rheumatol"},{"key":"1891_CR17","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1177\/2050640620934911","volume":"8","author":"JM Lohr","year":"2020","unstructured":"Lohr\u00a0JM, Beuers\u00a0U, Vujasinovic\u00a0M et\u00a0al (2020) European Guideline on IgG\u00a04-related digestive disease\u2014UEG and SGF evidence-based recommendations. United European Gastroenterol\u00a0J 8:637\u2013666","journal-title":"United European Gastroenterol J"},{"key":"1891_CR18","doi-asserted-by":"publisher","first-page":"787422","DOI":"10.3389\/fimmu.2021.787422","volume":"12","author":"M Maslinska","year":"2021","unstructured":"Maslinska\u00a0M, Dmowska-Chalaba\u00a0J, Jakubaszek\u00a0M (2021) The Role of IgG\u00a04 in Autoimmunity and Rheumatic Diseases. Front Immunol 12:787422","journal-title":"Front Immunol"},{"key":"1891_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","volume":"134","author":"H Mattoo","year":"2014","unstructured":"Mattoo\u00a0H, Mahajan\u00a0VS, Della-Torre\u00a0E et\u00a0al (2014) De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG\u00a04-related disease. J\u00a0Allergy Clin Immunol 134:679\u2013687","journal-title":"J Allergy Clin Immunol"},{"key":"1891_CR20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo\u00a0H, Mahajan\u00a0VS, Maehara\u00a0T et\u00a0al (2016) Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG\u00a04-related disease. J\u00a0Allergy Clin Immunol 138:825\u2013838","journal-title":"J Allergy Clin Immunol"},{"key":"1891_CR21","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00393-016-0138-7","volume":"75","author":"F Moosig","year":"2016","unstructured":"Moosig\u00a0F, Schirmer\u00a0JH, Lamprecht\u00a0P, Holle\u00a0JU (2016) Clinical spectrum of IgG\u00a04-related diseases and the connection to rheumatology. Z\u00a0Rheumatol 75:675\u2013680","journal-title":"Z Rheumatol"},{"key":"1891_CR22","doi-asserted-by":"publisher","first-page":"8054","DOI":"10.1038\/s41467-024-52470-8","volume":"15","author":"TA Olafsdottir","year":"2024","unstructured":"Olafsdottir\u00a0TA, Thorleifsson\u00a0G, Lopez De Lapuente Portilla\u00a0A et\u00a0al (2024) Sequence variants influencing the regulation of serum IgG subclass levels. Nat Commun 15:8054","journal-title":"Nat Commun"},{"key":"1891_CR23","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1136\/ard-2023-224487","volume":"83","author":"L Peng","year":"2024","unstructured":"Peng\u00a0L, Nie\u00a0Y, Zhou\u00a0J et\u00a0al (2024) Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG\u00a04-RD (WInS IgG\u00a04-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial. Ann Rheum Dis 83:651\u2013660","journal-title":"Ann Rheum Dis"},{"key":"1891_CR24","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41584-020-0500-7","volume":"16","author":"CA Perugino","year":"2020","unstructured":"Perugino\u00a0CA, Stone\u00a0JH (2020) IgG\u00a04-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol 16:702\u2013714","journal-title":"Nat Rev Rheumatol"},{"key":"1891_CR25","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1016\/S2665-9913(23)00157-1","volume":"5","author":"CA Perugino","year":"2023","unstructured":"Perugino\u00a0CA, Wallace\u00a0ZS, Zack\u00a0DJ et\u00a0al (2023) Evaluation of the safety, efficacy, and mechanism of action of obexelimab for the treatment of patients with IgG\u00a04-related disease: an open-label, single-arm, single centre, phase\u00a02 pilot trial. Lancet Rheumatol 5:e442\u2013e450","journal-title":"Lancet Rheumatol"},{"key":"1891_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","volume":"23","author":"T Rispens","year":"2023","unstructured":"Rispens\u00a0T, Huijbers\u00a0MG (2023) The unique properties of IgG\u00a04 and its roles in health and disease. Nat Rev Immunol 23:763\u2013778","journal-title":"Nat Rev Immunol"},{"issue":"112","key":"1891_CR27","first-page":"186","volume":"36","author":"T Sasaki","year":"2018","unstructured":"Sasaki\u00a0T, Akiyama\u00a0M, Kaneko\u00a0Y et\u00a0al (2018) Risk factors of relapse following glucocorticoid tapering in IgG\u00a04-related disease. Clin Exp Rheumatol 36(112):186\u2013189","journal-title":"Clin Exp Rheumatol"},{"key":"1891_CR28","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/gutjnl-2015-310336","volume":"65","author":"M Shiokawa","year":"2016","unstructured":"Shiokawa\u00a0M, Kodama\u00a0Y, Kuriyama\u00a0K et\u00a0al (2016) Pathogenicity of IgG in patients with IgG\u00a04-related disease. Gut 65:1322\u20131332","journal-title":"Gut"},{"key":"1891_CR29","doi-asserted-by":"crossref","unstructured":"Stone JH, Khosroshahi A, Zhang W et\u00a0al (2024) Inebilizumab for Treatment of IgG\u00a04-Related Disease. N\u00a0Engl J Med","DOI":"10.1056\/NEJMoa2409712"},{"key":"1891_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone\u00a0JH, Zen\u00a0Y, Deshpande\u00a0V (2012) IgG\u00a04-related disease. N\u00a0Engl J Med 366:539\u2013551","journal-title":"N Engl J Med"},{"key":"1891_CR31","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.nmd.2023.04.004","volume":"33","author":"SC Suresh","year":"2023","unstructured":"Suresh\u00a0SC, Hasan\u00a0A, Zonnoor\u00a0SL et\u00a0al (2023) Can IgG\u00a04-related disease present as isolated myositis? Neuromuscul Disord 33:570\u2013574","journal-title":"Neuromuscul Disord"},{"key":"1891_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/mr\/roac141","volume":"33","author":"Y Tanaka","year":"2023","unstructured":"Tanaka\u00a0Y, Stone\u00a0JH (2023) Perspectives on current and emerging therapies for immunoglobulin G4-related disease. Mod Rheumatol 33:229\u2013236","journal-title":"Mod Rheumatol"},{"key":"1891_CR33","doi-asserted-by":"publisher","first-page":"20210105","DOI":"10.1259\/bjr.20210105","volume":"94","author":"CYL Tang","year":"2021","unstructured":"Tang\u00a0CYL, Chua\u00a0WM, Cheng\u00a0LTJ et\u00a0al (2021) (18)F-FDG PET\/CT Manifestations of IgG\u00a04-related Disease. Br J Radiol 94:20210105","journal-title":"Br J Radiol"},{"key":"1891_CR34","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2665-9913(19)30006-2","volume":"1","author":"C Terao","year":"2019","unstructured":"Terao\u00a0C, Ota\u00a0M, Iwasaki\u00a0T et\u00a0al (2019) IgG\u00a04-related disease in the Japanese population: a\u00a0genome-wide association study. Lancet Rheumatol 1:e14\u2013e22","journal-title":"Lancet Rheumatol"},{"key":"1891_CR35","doi-asserted-by":"publisher","first-page":"rkae020","DOI":"10.1093\/rap\/rkae020","volume":"8","author":"ZS Wallace","year":"2024","unstructured":"Wallace\u00a0ZS, Katz\u00a0G, Hernandez-Barco\u00a0YG, Baker\u00a0MC (2024) Current and future advances in practice: IgG\u00a04-related disease. Rheumatol Adv Pract 8:rkae20","journal-title":"Rheumatol Adv Pract"},{"key":"1891_CR36","first-page":"1000","volume":"55","author":"ZS Wallace","year":"2016","unstructured":"Wallace\u00a0ZS, Mattoo\u00a0H, Mahajan\u00a0VS et\u00a0al (2016) Predictors of disease relapse in IgG\u00a04-related disease following rituximab. Baillieres Clin Rheumatol 55:1000\u20131008 (Oxford)","journal-title":"Baillieres Clin Rheumatol"},{"key":"1891_CR37","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/ard-2023-223950","volume":"82","author":"ZS Wallace","year":"2023","unstructured":"Wallace\u00a0ZS, Miles\u00a0G, Smolkina\u00a0E et\u00a0al (2023) Incidence, prevalence and mortality of IgG\u00a04-related disease in the USA: a\u00a0claims-based analysis of commercially insured adults. Ann Rheum Dis 82:957\u2013962","journal-title":"Ann Rheum Dis"},{"key":"1891_CR38","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace\u00a0ZS, Naden\u00a0RP, Chari\u00a0S et\u00a0al (2020) The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG\u00a04-related disease. Ann Rheum Dis 79:77\u201387","journal-title":"Ann Rheum Dis"},{"key":"1891_CR39","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00296-017-3765-7","volume":"38","author":"S Yadlapati","year":"2018","unstructured":"Yadlapati\u00a0S, Verheyen\u00a0E, Efthimiou\u00a0P (2018) IgG\u00a04-related disease: a\u00a0complex under-diagnosed clinical entity. Rheumatol Int 38:169\u2013177","journal-title":"Rheumatol Int"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01891-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01891-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01891-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:35:00Z","timestamp":1757158500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01891-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1891"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01891-8","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"12 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Krasselt und B.\u00a0Hoyer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}